As Paxlovid is “blunting SARS[-CoV-]2 disease pathogenesis,” there are multiple transmissible coronavirus variants circulating resistant to the antiviral’s main ingredient, according to a study published March 29 in Science Advances.
Read the full post on Becker's Hospital Review - Healthcare News
